Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

First Tracks Biotherapeutics, Inc. (TRAX)

Healthcare Biotechnology
44.00 $
-7.8% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns First Tracks Biotherapeutics, Inc. (TRAX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 89.0% of the shares are freely tradable; institutional investors hold 46.0%.

Ownership Structure

Institutional ownership
46.0%
Insiders
6.6%
Float
89.0%
Shares Outstanding
35Mio.

Largest Shareholders

Funds

Funds TRAX
Name Stake (%) Shares Change (%) Date
Vanguard Total Stock Mkt Idx Inv 2.20 768,570 +0.0 04/30/2026
State Street® SPDR® S&P® Biotech ETF 1.61 560,155 -0.6 05/31/2026
iShares Russell 2000 ETF 1.26 441,240 +0.9 05/29/2026
Nuveen Quant Small Cap Equity R6 0.77 269,060 +0.0 04/30/2026
Vanguard Institutional Extnd Mkt Idx Tr 0.63 221,331 +0.0 04/30/2026
Fidelity Advisor Biotechnology I 0.43 148,400 +0.0 04/30/2026
iShares Russell 2000 Growth ETF 0.42 148,222 -0.6 05/29/2026
State St Russell Sm/Mid Cp® Indx SL Cl I 0.35 121,994 +0.0 05/31/2026
Fidelity Extended Market Index 0.30 104,369 +0.0 04/30/2026
Schwab US Small-Cap ETF™ 0.27 94,549 +0.1 05/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?